UNSPSC 51144109: Amphetamine phosphate

This classification denotes a cns stimulant with the molecular formula C9H13N.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 163DO59R3J. European Medicines Agency schedules amfetamine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB36020. Most nations, for tariff and trade purposes, schedule amphetamine phosphate under HS 29214600. As of Q4 2014, AMPHETAMINE PHOSPHATE remains US FDA's Preferred Term for this commodity. SMILES: CC(CC1CCCCC1)N.OP(=O)(O)O.

UNSPSC 51144109 Amphetamine phosphate is a Commodity code that nominally covers pharmaceutical chemical compounds, but state and local governments show no recent procurement activity aligned with this specific substance. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health support, which falls outside the scope of amphetamine phosphate procurement. No issuing bodies are documented as repeat buyers under this code, and no pattern of state or local demand for amphetamine phosphate emerges from current market activity.

Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. This procurement represents community health and harm-reduction support rather than pharmaceutical substance procurement and does not reflect typical demand under the amphetamine phosphate code. No other state or local opportunities tagged to this code appear in the recent-opportunities block, indicating minimal current procurement activity in this category across state and local jurisdictions.